- Home
- CRGX vs OLP Comparison
CRGX vs OLP Comparison
Compare CRGX & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- OLP
- Stock Information
- Founded
- CRGX 2021
- OLP 1982
- Country
- CRGX United States
- OLP United States
- Employees
- CRGX N/A
- OLP N/A
- Industry
- CRGX
- OLP Real Estate Investment Trusts
- Sector
- CRGX
- OLP Real Estate
- Exchange
- CRGX Nasdaq
- OLP Nasdaq
- Market Cap
- CRGX 190.0M
- OLP 569.9M
- IPO Year
- CRGX 2023
- OLP N/A
- Fundamental
- Price
- CRGX $4.61
- OLP $23.75
- Analyst Decision
- CRGX Hold
- OLP Strong Buy
- Analyst Count
- CRGX 7
- OLP 1
- Target Price
- CRGX $5.33
- OLP $28.00
- AVG Volume (30 Days)
- CRGX 2.0M
- OLP 80.2K
- Earning Date
- CRGX 08-11-2025
- OLP 08-05-2025
- Dividend Yield
- CRGX N/A
- OLP 7.61%
- EPS Growth
- CRGX N/A
- OLP N/A
- EPS
- CRGX N/A
- OLP 1.35
- Revenue
- CRGX N/A
- OLP $92,152,000.00
- Revenue This Year
- CRGX $57.81
- OLP $11.87
- Revenue Next Year
- CRGX N/A
- OLP $4.72
- P/E Ratio
- CRGX N/A
- OLP $17.57
- Revenue Growth
- CRGX N/A
- OLP 3.31
- 52 Week Low
- CRGX $3.00
- OLP $22.32
- 52 Week High
- CRGX $25.45
- OLP $30.45
- Technical
- Relative Strength Index (RSI)
- CRGX 61.57
- OLP 48.08
- Support Level
- CRGX $4.32
- OLP $23.79
- Resistance Level
- CRGX $4.63
- OLP $24.36
- Average True Range (ATR)
- CRGX 0.15
- OLP 0.48
- MACD
- CRGX 0.04
- OLP -0.01
- Stochastic Oscillator
- CRGX 76.44
- OLP 57.72
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.